Asset profile
QL1706
Multispecific antibody
Phase 3underway
Evidence outlook · registrational
Non-Small Cell Lung Cancer: registrational readout pending
Its supporting mid-stage evidence has not yet been graded on this platform. Registrational readout expected around 2027-08-31.
How the evidence outlook works ↗
Featured trials
The studies most instrumental to this drug's clinical progression, individually graded on design and result. Pick an indication; Research unlocks the trials, endpoints, key results and grades.
Competitive landscape
63 competitors in this universe: 3 direct rivals (same mechanism and indication), 0 same-class, 60 same-indication; 58 further along in development.
Unlock with Research ↗
| Drug | Stage | Modality | Mechanism | Evidence signal | Reported efficacygraded featured trials |
|---|---|---|---|---|---|
| QL1706: this drug | Phase 3 | Multispecific antibody | PD-1 x CTLA-4 | ||
| MEDI5752 | Phase 3 | Multispecific antibody | PD-1 x CTLA-4 | ||
| SI-B003 | Phase 2 | Multispecific antibody | PD-1 x CTLA-4 | ||
| AI-061 | Phase 1 | Combination | PD-1 x CTLA-4 | ||
| Afatinib (Gilotrif) | Approved | Small molecule | EGFR/HER1, HER2, HER4 | ||
| Alectinib (Alecensa) | Approved | Small molecule | ALK | ||
| Alymsys (bevacizumab-Maly) | Approved | Monoclonal antibody | VEGF-A | ||
| Amivantamab | Approved | Multispecific antibody | EGFR x c-MET | ||
| Atezolizumab | Approved | Monoclonal antibody | PD-L1 | ||
| BAT1706 (Avzivi) | Approved | Monoclonal antibody | VEGF-A | ||
| BAY2927088 (Hyrnuo) | Approved | Small molecule | HER2 (ERBB2) exon 20 insertions and point mutations; also mutant-selective EGFR | ||
| Bevacizumab | Approved | Monoclonal antibody | VEGF-A, Vascular Endothelial Growth Factor Inhibitor | ||
| Bevacizumab-Awwb (MVASI) | Approved | Monoclonal antibody | VEGF-A | ||
| Binimetinib | Approved | Small molecule | MEK1/2 | ||
| Brigatinib | Approved | Small molecule | ALK | ||
| Capmatinib | Approved | Small molecule | MET |
…and 48 more. Research shows the complete landscape.
Research
Unlock with Research ↗Unlock the full comparison
Research adds each competitor's evidence grade and sourced trial results, aligned per race, so you can see who actually has the data.
Upcoming events
(144 total)
Estimated primary-completion dates from ClinicalTrials.gov. These are registry estimates, never confirmed readout dates; they can move as trials progress.
2026 (11)
October 2026 (3)
Phase 1/2Malignant Mesothelioma, MesotheliomaNot yet recruiting
Est. primary completion 2026-10-31 · NCT07131345 · CT.gov ↗
What to watch
Phase 2HER2 Negative, Low PD-L1 Expressing, Unresectable or Metastatic Gastric/Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2026-10-31 · NCT06932068 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular Carcinoma (HCC)Recruiting
Est. primary completion 2026-10-31 · NCT07268131 · CT.gov ↗
What to watch
December 2026 (8)
Phase 2HR-positive/HER2-negative Breast CancerRecruiting
Est. primary completion 2026-12 · NCT07396324 · CT.gov ↗
What to watch
Phase 2Esophageal Squamous Cell Carcinoma (ESCC)Recruiting
Est. primary completion 2026-12 · NCT07290010 · CT.gov ↗
What to watch
Phase 2Biliary Tract TumorsActive not recruiting
Est. primary completion 2026-12 · NCT06892925 · CT.gov ↗
What to watch
Phase 1/2Leptomeningeal Metastasis, Pemetrexed, PD-1 Inhibitor, CTLA4, Solid TumorsActive not recruiting
Est. primary completion 2026-12-01 · NCT06809530 · CT.gov ↗
What to watch
Phase 2Locally Advanced Rectal Cancer With Liver MetastasesRecruiting
Est. primary completion 2026-12-01 · NCT06787183 · CT.gov ↗
What to watch
Phase 2Recurrent or Metastatic Endometrial CancerNot yet recruiting
Est. primary completion 2026-12-30 · NCT06751277 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2026-12-31 · NCT07271602 · CT.gov ↗
What to watch
Phase 2Locally Advanced Resectable Esophageal Squamous Cell CarcinomaRecruiting
Est. primary completion 2026-12-31 · NCT06908382 · CT.gov ↗
What to watch
2027 (73)
January 2027 (1)
Phase 2Rectal Cancer PatientsRecruiting
Est. primary completion 2027-01-01 · NCT07291401 · CT.gov ↗
What to watch
February 2027 (3)
Phase 2Colorectal Cancer Liver MetastasisRecruiting
Est. primary completion 2027-02-01 · NCT06801665 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-02-25 · NCT06897046 · CT.gov ↗
What to watch
Phase 2Recurrent Cervical CancerNot yet recruiting
Est. primary completion 2027-02-28 · NCT07172217 · CT.gov ↗
What to watch
March 2027 (3)
Phase 2Esophageal Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2027-03-01 · NCT07049185 · CT.gov ↗
What to watch
Phase 2Previously Treated HER2-negative Breast Cancer Patients With Homologous Recombination DeficiencyNot yet recruiting
Est. primary completion 2027-03-30 · NCT07113964 · CT.gov ↗
What to watch
Phase 2Neoadjuvant Immunotherapy, Locally Advanced Cervical CancerActive not recruiting
Est. primary completion 2027-03-30 · NCT07205497 · CT.gov ↗
What to watch
April 2027 (5)
Phase 1/2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-04 · NCT07453394 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-04 · NCT07139041 · CT.gov ↗
What to watch
Phase 1/2Intermediate Trophoblastic TumorRecruiting
Est. primary completion 2027-04-16 · NCT06941766 · CT.gov ↗
What to watch
Phase 2Second-Line Therapy for Unresectable or Metastatic Biliary Tract CancerRecruiting
Est. primary completion 2027-04-30 · NCT07530445 · CT.gov ↗
What to watch
Phase 2Endometrial Adenocarcinoma, Endometrial CancerRecruiting
Est. primary completion 2027-04-30 · NCT06917092 · CT.gov ↗
What to watch
May 2027 (5)
Phase 2Bone and Soft Tissue TumorsRecruiting
Est. primary completion 2027-05-01 · NCT06939855 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma ResectableRecruiting
Est. primary completion 2027-05-01 · NCT07014150 · CT.gov ↗
What to watch
Phase 2Metastatic Pancreatic CancerRecruiting
Est. primary completion 2027-05-15 · NCT06951997 · CT.gov ↗
What to watch
Phase 2Triple-Negative Breast Cancer (TNBC)Not yet recruiting
Est. primary completion 2027-05-30 · NCT07005583 · CT.gov ↗
What to watch
Phase 2Breast Cancer, HR+/HER2- Breast CancerRecruiting
Est. primary completion 2027-05-31 · NCT06967103 · CT.gov ↗
What to watch
June 2027 (5)
Phase 1/2Metastatic Solid TumorsNot yet recruiting
Est. primary completion 2027-06 · NCT07272590 · CT.gov ↗
What to watch
Phase 2Extensive Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-06-01 · NCT07083375 · CT.gov ↗
What to watch
Phase 3Ovarian Clear Cell CarcinomaRecruiting
Est. primary completion 2027-06-01 · NCT07002346 · CT.gov ↗
What to watch
Phase 2BRAF V600 Colorectal CancerRecruiting
Est. primary completion 2027-06-30 · NCT07150247 · CT.gov ↗
What to watch
Phase 2Colon Cancer, MSS/pMMR, QL1706Not yet recruiting
Est. primary completion 2027-06-30 · NCT07156682 · CT.gov ↗
What to watch
July 2027 (3)
Early phase / not applicableLocally Advanced Rectal Cancer (LARC), 5-12cm to Anal VergeNot yet recruiting
Est. primary completion 2027-07-01 · NCT07769853 · CT.gov ↗
What to watch
Phase 2Hepatocellular Carcinoma (HCC), Second Line TreatmentActive not recruiting
Est. primary completion 2027-07-31 · NCT07138885 · CT.gov ↗
What to watch
Phase 2Gastric Cancer (GC)Not yet recruiting
Est. primary completion 2027-07-31 · NCT07045805 · CT.gov ↗
What to watch
August 2027 (10)
Phase 1TNBC, Triple Negative Breast CancerRecruiting
Est. primary completion 2027-08-01 · NCT07178171 · CT.gov ↗
What to watch
Phase 2Intrahepatic Cholangiocarcinoma (Icc)Recruiting
Est. primary completion 2027-08-01 · NCT07070700 · CT.gov ↗
What to watch
Phase 2Limited-stage Small Cell Lung Cancer (LS-SCLC), Chemoradiotherapy, Induction Therapy, Consolidation ImmunotherapyRecruiting
Est. primary completion 2027-08-01 · NCT07091305 · CT.gov ↗
What to watch
Phase 2Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaRecruiting
Est. primary completion 2027-08-01 · NCT07090317 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular Carcinoma (HCC)Not yet recruiting
Est. primary completion 2027-08-26 · NCT07115550 · CT.gov ↗
What to watch
Phase 2dMMR/MSI-H-type Rectal AdenocarcinomaActive not recruiting
Est. primary completion 2027-08-30 · NCT07160647 · CT.gov ↗
What to watch
Phase 2Colorectal CancerNot yet recruiting
Est. primary completion 2027-08-31 · NCT07353268 · CT.gov ↗
What to watch
Phase 2mCRCNot yet recruiting
Est. primary completion 2027-08-31 · NCT07116577 · CT.gov ↗
What to watch
Phase 2Advance Pancreatic CancerRecruiting
Est. primary completion 2027-08-31 · NCT07110064 · CT.gov ↗
What to watch
Phase 3Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-08-31 · NCT05487391 · CT.gov ↗
What to watch
September 2027 (9)
Phase 2Advanced Breast CancerRecruiting
Est. primary completion 2027-09 · NCT07180160 · CT.gov ↗
What to watch
Phase 2AFP Gastric or Gastroesophageal Junction Adenocarcinoma, PD-1/CTLA-4, AFPGC, ImmunotherapyRecruiting
Est. primary completion 2027-09 · NCT07289997 · CT.gov ↗
What to watch
Phase 2Gastroesophageal Junction Adenocarcinoma, Gastric AdenocarcinomaActive not recruiting
Est. primary completion 2027-09 · NCT07776639 · CT.gov ↗
What to watch
Phase 2/3Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2027-09-01 · NCT05976568 · CT.gov ↗
What to watch
Phase 2TNBC, Triple Negative Breast CancerRecruiting
Est. primary completion 2027-09-15 · NCT07601178 · CT.gov ↗
What to watch
Phase 2Triple-negative Breast Cancer (TNBC)Not yet recruiting
Est. primary completion 2027-09-30 · NCT07509515 · CT.gov ↗
What to watch
Phase 2Neoadjuvant Treatment for Locally Advanced Cervical CancerRecruiting
Est. primary completion 2027-09-30 · NCT07286253 · CT.gov ↗
What to watch
Phase 2HCC - Hepatocellular CarcinomaNot yet recruiting
Est. primary completion 2027-09-30 · NCT06884982 · CT.gov ↗
What to watch
Phase 2Treatment of Recurrent Ovarian CancerRecruiting
Est. primary completion 2027-09-30 · NCT07286240 · CT.gov ↗
What to watch
October 2027 (3)
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-10 · NCT07134413 · CT.gov ↗
What to watch
Phase 2Cervical Cancer, Cervical Cancer Metastatic, Cervical Cancer Recurrent, Cervical Adenocarcinoma, Cervical Cancer Squamous CellNot yet recruiting
Est. primary completion 2027-10-01 · NCT07141186 · CT.gov ↗
What to watch
Phase 2HCC - Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-10-01 · NCT07776080 · CT.gov ↗
What to watch
November 2027 (4)
Phase 2Biliary Tract Cancer (BTC), First-line TherapyNot yet recruiting
Est. primary completion 2027-11 · NCT07129018 · CT.gov ↗
What to watch
Phase 2Breast CancerNot yet recruiting
Est. primary completion 2027-11-01 · NCT07197697 · CT.gov ↗
What to watch
Phase 1DC-CIK Treatment, Regorafenib, Colorectal Cancer, Immune Combination Therapy, Iparomlimab and Tuvonralimab InjectionRecruiting
Est. primary completion 2027-11-30 · NCT07343791 · CT.gov ↗
What to watch
Phase 2Gastric Cancer Adenocarcinoma MetastaticRecruiting
Est. primary completion 2027-11-30 · NCT07392346 · CT.gov ↗
What to watch
December 2027 (22)
Phase 2Non-Small Cell Lung CancerRecruiting
Est. primary completion 2027-12 · NCT07082179 · CT.gov ↗
What to watch
Phase 2Hepatocellular CarcinomaRecruiting
Est. primary completion 2027-12 · NCT07179900 · CT.gov ↗
What to watch
Phase 2Cervical Cancer Stage IVBNot yet recruiting
Est. primary completion 2027-12 · NCT06882447 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-12-01 · NCT07200947 · CT.gov ↗
What to watch
Early phase / not applicableHepatocellular Carcinoma(HCC)Recruiting
Est. primary completion 2027-12-15 · NCT06893887 · CT.gov ↗
What to watch
Phase 2Non-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2027-12-18 · NCT07286942 · CT.gov ↗
What to watch
Phase 2Triple Negative Breast Cancer (TNBC)Recruiting
Est. primary completion 2027-12-25 · NCT07342283 · CT.gov ↗
What to watch
Phase 2Hepatecellular Carcinoma, RALOX-HAIC（Hepatic Arterial Infusion Chemotherapy With Raltitrexed and Oxaliplatin, Bevacizumab …Recruiting
Est. primary completion 2027-12-30 · NCT07327788 · CT.gov ↗
What to watch
Phase 2Gastric/Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2027-12-30 · NCT07148427 · CT.gov ↗
What to watch
Phase 2Lung AdenocarcinomaNot yet recruiting
Est. primary completion 2027-12-31 · NCT07416058 · CT.gov ↗
What to watch
Phase 2Breast CancerNot yet recruiting
Est. primary completion 2027-12-31 · NCT07246317 · CT.gov ↗
What to watch
Phase 2Local Advanced Esophageal CancerNot yet recruiting
Est. primary completion 2027-12-31 · NCT07530549 · CT.gov ↗
What to watch
Phase 2Iparomlimab and Tuvonralimab, Clear Cell Renal Cell Carcinoma, Neoadjuvant TherapyRecruiting
Est. primary completion 2027-12-31 · NCT07389629 · CT.gov ↗
What to watch
Phase 2Locally Advanced Nasopharyngeal Carcinoma, Immunotherapy, Induction TherapyRecruiting
Est. primary completion 2027-12-31 · NCT07085234 · CT.gov ↗
What to watch
Phase 2Soft Tissue Sarcoma (STS)Not yet recruiting
Est. primary completion 2027-12-31 · NCT07205185 · CT.gov ↗
What to watch
Phase 2Gastric Cancer (GC), Gastroesophageal Junction Cancer, Advanced Gastric Cancer, Metastatic Gastric CancerRecruiting
Est. primary completion 2027-12-31 · NCT07315854 · CT.gov ↗
What to watch
Phase 2Ovarian CancersNot yet recruiting
Est. primary completion 2027-12-31 · NCT07407452 · CT.gov ↗
What to watch
Phase 2Endometrial Cancer, Immunotherapy, Mismatch Repair DeficiencyNot yet recruiting
Est. primary completion 2027-12-31 · NCT07369986 · CT.gov ↗
What to watch
Phase 2Gastric / Gastroesophageal Junction Adenocarcinoma, MSI-H CancerRecruiting
Est. primary completion 2027-12-31 · NCT07127822 · CT.gov ↗
What to watch
Phase 2ES-SCLCNot yet recruiting
Est. primary completion 2027-12-31 · NCT07349225 · CT.gov ↗
What to watch
Phase 2Head and Neck Cancer, Radiotherapy, Anti-PD-1/CTLA-4 AntibodyRecruiting
Est. primary completion 2027-12-31 · NCT07447570 · CT.gov ↗
What to watch
Early phase / not applicableSquamous Cell Carcinoma of Head and NeckRecruiting
Est. primary completion 2027-12-31 · NCT07546383 · CT.gov ↗
What to watch
2028 (43)
January 2028 (2)
February 2028 (3)
Phase 2Metastatic Colorectal Cancer With Left-sided Primary Tumor, ImmunotherapyNot yet recruiting
Est. primary completion 2028-02-28 · NCT07070713 · CT.gov ↗
What to watch
Phase 2Locally Advanced Gastric/Gastroesophageal Junction AdenocarcinomaRecruiting
Est. primary completion 2028-02-29 · NCT06829797 · CT.gov ↗
What to watch
Phase 2Advanced Intrahepatic CholangiocarcinomaNot yet recruiting
Est. primary completion 2028-02-29 · NCT07152769 · CT.gov ↗
What to watch
March 2028 (6)
Phase 3Small-cell Lung CancerNot yet recruiting
Est. primary completion 2028-03 · NCT06789796 · CT.gov ↗
What to watch
Phase 1Rectal CancerNot yet recruiting
Est. primary completion 2028-03-01 · NCT06931873 · CT.gov ↗
What to watch
Phase 1/2Recurrent or Metastatic Cervical CancerNot yet recruiting
Est. primary completion 2028-03-31 · NCT07542717 · CT.gov ↗
What to watch
Phase 2Cervical CancersRecruiting
Est. primary completion 2028-03-31 · NCT06878222 · CT.gov ↗
What to watch
Phase 2BTCNot yet recruiting
Est. primary completion 2028-03-31 · NCT07263360 · CT.gov ↗
What to watch
Phase 4Gastric Cancer (Diagnosis), Gastric Cancer (GC), Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2028-03-31 · NCT07502027 · CT.gov ↗
What to watch
April 2028 (1)
Phase 2Locally Advanced Nasopharyngeal Squamous Cell CarcinomaNot yet recruiting
Est. primary completion 2028-04-30 · NCT07135804 · CT.gov ↗
What to watch
May 2028 (2)
June 2028 (7)
Phase 2Biliary Tract Cancer (BTC)Recruiting
Est. primary completion 2028-06-01 · NCT07733115 · CT.gov ↗
What to watch
Phase 2Breast CancerNot yet recruiting
Est. primary completion 2028-06-01 · NCT07782840 · CT.gov ↗
What to watch
Phase 2Cervical Cancer, Neoadjuvant Therapy, ImmunotherapyNot yet recruiting
Est. primary completion 2028-06-15 · NCT07617818 · CT.gov ↗
What to watch
Early phase / not applicableTriple Negative Breast Cancer (TNBC)Not yet recruiting
Est. primary completion 2028-06-15 · NCT07187674 · CT.gov ↗
What to watch
Phase 2QL1706, ESCC, First-line TherapyNot yet recruiting
Est. primary completion 2028-06-30 · NCT07533305 · CT.gov ↗
What to watch
Phase 2Cervical CancerRecruiting
Est. primary completion 2028-06-30 · NCT07256236 · CT.gov ↗
What to watch
July 2028 (4)
Phase 3Metastatic Colorectal CancerNot yet recruiting
Est. primary completion 2028-07 · NCT07025239 · CT.gov ↗
What to watch
Phase 2Gastric CancerNot yet recruiting
Est. primary completion 2028-07-01 · NCT07595523 · CT.gov ↗
What to watch
Phase 2CancerNot yet recruiting
Est. primary completion 2028-07-09 · NCT07041788 · CT.gov ↗
What to watch
Phase 2Nasopharyngeal Carcinoma (NPC), First-line Treatment Failure Nasopharyngeal CarcinomaRecruiting
Est. primary completion 2028-07-16 · NCT07101744 · CT.gov ↗
What to watch
August 2028 (1)
Phase 2Urologic NeoplasmsNot yet recruiting
Est. primary completion 2028-08-15 · NCT07741617 · CT.gov ↗
What to watch
September 2028 (1)
Phase 2Immunotherapy, Gastric Cancer (GC), Radiotherapy, Neoadjuvant Therapy, Neoadjuvant ChemoimmunotherapyRecruiting
Est. primary completion 2028-09-23 · NCT07165847 · CT.gov ↗
What to watch
November 2028 (1)
Phase 2Esophageal Squamous CarcinomaNot yet recruiting
Est. primary completion 2028-11-30 · NCT07490002 · CT.gov ↗
What to watch
December 2028 (15)
Phase 2Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2028-12 · NCT07151209 · CT.gov ↗
What to watch
Early phase / not applicableNon-Small Cell Lung CancerRecruiting
Est. primary completion 2028-12 · NCT07452003 · CT.gov ↗
What to watch
Phase 2Uterine Cervical Neoplasms, Locally AdvancedRecruiting
Est. primary completion 2028-12-01 · NCT07646301 · CT.gov ↗
What to watch
Phase 3Nasopharyngeal Cancinoma (NPC), Nasopharyngeal CancerRecruiting
Est. primary completion 2028-12-01 · NCT06749899 · CT.gov ↗
What to watch
Phase 2Breast Cancer, Neoadjuvant Therapy, Immune Checkpoint Inhibitors, QL1706Recruiting
Est. primary completion 2028-12-30 · NCT07372079 · CT.gov ↗
What to watch
Phase 2/3Small Cell Lung CancerNot yet recruiting
Est. primary completion 2028-12-30 · NCT07636226 · CT.gov ↗
What to watch
Phase 3Colorectal Cancer Metastatic, Microsatellite Stable (MSS) Colorectal Cancer (CRC)Not yet recruiting
Est. primary completion 2028-12-30 · NCT07729605 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal Cancer (CRC)Not yet recruiting
Est. primary completion 2028-12-31 · NCT07446387 · CT.gov ↗
What to watch
Phase 2Colon Cancer, Synchronous Liver MetastasesNot yet recruiting
Est. primary completion 2028-12-31 · NCT07649473 · CT.gov ↗
What to watch
Phase 2Gastric Cancer Stage IIINot yet recruiting
Est. primary completion 2028-12-31 · NCT07315035 · CT.gov ↗
What to watch
Phase 2Gastric or Gastroesophageal Junction AdenocarcinomaNot yet recruiting
Est. primary completion 2028-12-31 · NCT07400315 · CT.gov ↗
What to watch
Phase 2Metastatic Colorectal Cancer (CRC), mCRCNot yet recruiting
Est. primary completion 2028-12-31 · NCT07502014 · CT.gov ↗
What to watch
Phase 2Ovarian CancerNot yet recruiting
Est. primary completion 2028-12-31 · NCT07673835 · CT.gov ↗
What to watch
Phase 2Resectable Hepatocellular Carcinoma With High Risk of RecurrenceRecruiting
Est. primary completion 2028-12-31 · NCT06954116 · CT.gov ↗
What to watch
Phase 4PD-(L)1, CTLA-4, Advanced Melanoma, Iparomlimab, Tuvonralimab, BevacizumabNot yet recruiting
Est. primary completion 2028-12-31 · NCT07004335 · CT.gov ↗
What to watch
2029 (12)
January 2029 (1)
Phase 2Hepato Cellular Carcinoma (HCC)Recruiting
Est. primary completion 2029-01-15 · NCT07328009 · CT.gov ↗
What to watch
February 2029 (2)
April 2029 (1)
Phase 2Ovarian CancersNot yet recruiting
Est. primary completion 2029-04 · NCT07663513 · CT.gov ↗
What to watch
May 2029 (1)
Early phase / not applicableNon-Small Cell Lung CancerNot yet recruiting
Est. primary completion 2029-05 · NCT07538193 · CT.gov ↗
What to watch
June 2029 (2)
July 2029 (2)
November 2029 (1)
Phase 2RCC, Renal Cell CancerNot yet recruiting
Est. primary completion 2029-11-30 · NCT07277972 · CT.gov ↗
What to watch
2030 (4)
January 2030 (1)
Early phase / not applicableTNBC, Adjuvant Therapy, Lymph Node PositiveRecruiting
Est. primary completion 2030-01-31 · NCT07622836 · CT.gov ↗
What to watch
August 2030 (1)
Phase 2Extrapulmonary Neuroendocrine Carcinoma (EP-NEC), QL1706, Lenvatinib, ChemotherapyNot yet recruiting
Est. primary completion 2030-08-01 · NCT07738159 · CT.gov ↗
What to watch
2032 (1)
August 2032 (1)
Phase 3Locally Advanced Cervical CarcinomaNot yet recruiting
Est. primary completion 2032-08-31 · NCT07613567 · CT.gov ↗
What to watch
All registered studies
Every ClinicalTrials.gov study of this drug's own program, grouped by indication and phase. Research unlocks the studies themselves: titles, statuses, dates and featured-trial cross-links.